A. Blythe Ryerson, PhD, MPH
A. Blythe Ryerson, PhD, MPH, joined CDC as an epidemiologist in the Division of Cancer Prevention and Control’s (DCPC’s) Epidemiology and Applied Research Branch in 2003. The majority of her work focused on the early detection of breast and ovarian cancer and research related to CDC’s National Breast and Cervical Cancer Early Detection Program. Additionally, Dr. Ryerson has provided epidemiologic expertise and leadership to the Division’s research, resources, and programs aimed at identifying and addressing the needs of cancer survivors.
In 2012, Dr. Ryerson took a position in the Cancer Surveillance Branch as lead of the Surveillance Research Team, and is now acting branch chief. She conducts and leads a number of data dissemination and research activities related to the National Program of Cancer Registries. She also provides epidemiological expertise for the Division’s Comparative Effectiveness Research and Patient-Centered Outcomes Research using CDC’s cancer surveillance data.
The most recent articles Dr. Ryerson has first-authored include—
- 2016 Pediatric quality of life in long-term survivors of childhood cancer treated with anthracyclines.
- 2016 Annual report to the nation on the status of cancer, 1975–2012, featuring the increasing incidence of liver cancer.
- 2015 Connecting the dots: linking the National Program of Cancer Registries and the needs of survivors and clinicians.
- 2015 Reported breast symptoms in the National Breast and Cervical Cancer Early Detection Program.